(MedPage Today) -- Amarin Pharma has not done enough to definitively show that its generic competitor, Hikma Pharmaceuticals, is infringing on Amarin's patents for its anti-hypertriglyceridemia drug icosapent ethyl (Vascepa), the Supreme Court...
(MedPage Today) -- SANTIAGO, Chile -- When a rare but deadly rodent-borne virus struck passengers on a cruise ship and seemed to be spreading, there were no treatments for those who fell ill and no vaccines to protect others. That was the case...
(MedPage Today) -- Cervical epidural spinal cord stimulation (SCS) accrued more evidence backing its safety and feasibility as a treatment for chronic upper-limb paresis in stroke survivors. In a pilot study, seven people got SCS neuroprosthetic...
(MedPage Today) -- One in five adults with private insurance was denied coverage for themselves or a family member for care their doctors recommended, according to a Commonwealth Fund report published on Thursday. Among more than 4,500 adults...
(MedPage Today) -- CHICAGO -- A study of women undergoing breast imaging showed a significantly lower incidence of breast cancer in those who had a history of treatment with GLP-1 agonists. Involving more than 30,000 women, the study showed...
(MedPage Today) -- Standard treatment with intravenous artesunate led to similar outcomes among children hospitalized with severe malaria whether they had Plasmodium falciparum genetic variants linked to artemisinin resistance or not, according...
(MedPage Today) -- The usual glomerular filtration rate (GFR) threshold could be applied for predicting patient outcomes based on measured (mGFR) values, a retrospective observational cohort study indicated. Among 6,174 patients, a baseline mGFR...
The EHR vendor accused SelfRx of retrieving over 100,000 records for financial gain in the high-profile lawsuit. Now, the chronic condition management firm said it doesn’t know who took the records.
MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, co-hosts of the Debunked Podcast, discussed the impact of Marty Makary’s resignation from the FDA, among other topics. The post Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices appeared first on MedCity News .
Otsuka’s Voyxact slowed the loss of kidney function after one year in patients with a chronic autoimmune kidney disease, but the benefit was less than expected.
The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with implications for lawsuits over so-called skinny labels.